CDDO, a PPAR-Î³ ligand, inhibits TPA-induced cell migration and invasion through a PPAR-Î³-independent mechanism.

Jang, Hye-Yeon; Hong, On-Yu; Youn, Hyun Jo; Jung, Jaeuk; Chung, Eun Yong; Jung, Sung Hoo; Kim, Jong-Suk.

Afiliação

Jang HY; Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk 54907, Republic of Korea.
Hong OY; Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk 54907, Republic of Korea.
Youn HJ; Department of Surgery, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Jeollabuk 54907, Republic of Korea.
Jung J; Department of Anesthesiology and Pain Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Chung EY; Department of Anesthesiology and Pain Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Jung SH; Department of Surgery, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Jeollabuk 54907, Republic of Korea.
Kim JS; Department of Biochemistry, Institute for Medical Sciences, Jeonbuk National University Medical School, Jeonju, Jeollabuk 54907, Republic of Korea.

Oncol Lett ; 24(4): 354, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36168309